Instrument Inactif

Autres langues Cepheid

Actions

US15670R1077

Equipement et technologie médicale avancés

Autres langues

15/02/17	Cepheid : Announces FDA Clearance Of Xpert® Xpress Flu And Xpert Xpress Flu/RSV
05/11/16	Cepheid : Danaher Completes Acquisition Of Cepheid
27/10/16	Cepheid : 30 Minute Or Less Molecular Flu/RSV Test Now Available Outside The US
24/10/16	Cepheid : Announces Receipt of Required Regulatory Clearances in Proposed Acquisition by Danaher Corporation
05/10/16	Cepheid : New Bladder Cancer Test Could Reduce Number Of Invasive Procedures Required For Recurrence Monitoring
15/09/16	Cepheid : Announces Expansion Of The Most Comprehensive Molecular C. Difficile Product Portfolio On The Market
12/09/16	Brower Piven Commences An Investigation Into The Proposed Sale Of Cepheid And Encourages Shareholders To Contact The Firm For Additional Information
09/09/16	CEPHEID SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Announces the Investigation of Cepheid (CPHD) Over the Proposed Sale of the Company to Danaher Corporation
09/09/16	Cepheid : Acquisition May Not Be in the Best Interests of CPHD Shareholders
09/09/16	SHAREHOLDER UPDATE: Brodsky & Smith, LLC Announces an Investigation of The Board of Directors of Cepheid -CPHD
08/09/16	Cepheid : Targets Development of a Point of Care HIV Viral Load Test From a Few Drops of Blood
07/09/16	Harwood Feffer LLP : Announces Investigation of Cepheid
07/09/16	Brower Piven Commences An Investigation Into The Proposed Sale Of Cepheid And Encourages Investors To Contact The Firm For Additional Information
06/09/16	Cepheid :'s Xpert TV Now Cleared For Testing Symptomatic And Asymptomatic Men
06/09/16	CEPHEID Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Sale to Danaher Corporation
06/09/16	CEPHEID Rigrodsky & Long, P.A. Announces Investigation Of Buyout
06/09/16	Cepheid : Danaher To Acquire Cepheid For $53.00 Per Share, Or Approximately $4 Billion
04/08/16	Cepheid : to Webcast Upcoming Financial Presentations
28/07/16	Cepheid : Reports Second Quarter 2016 Results
20/07/16	Cepheid : Technical Notes on Scientific & Technical Instruments' Stocks -- Trimble Navigation, Garmin, Keysight Technologies, and Cepheid
12/07/16	Cepheid : Announces Results Of Validation Study For Use Of Xpert HPV In Primary Cervical Cancer Screening
07/07/16	Cepheid : Schedules 2016 Second Quarter Results Announcement And Webcast
05/07/16	Cepheid : Opening Of Hammersmith Clinic Furthers The Revolution In Sexual Health Diagnostic Services
30/06/16	Cepheid : FDA Supports Expanded Claims for Xpert Carba-R Test for "Superbugs"
15/06/16	Cepheid : Announces World Health Organization Prequalification Of Xpert HIV-1 Qualitative Test